Based in San Francisco, Matthew leads the firm’s life science business advisory practice—an innovative resource that provides life sciences companies with business strategy, capabilities, and transactional support related to financings, company set-up, growth, commercialization, partnerships and M&A transactions.

Matthew is an experienced, high-impact business executive and corporate attorney who has held diverse operating roles of increasing responsibility across a wide range of successful private and public biopharma, digital health, med tech and precision medicine companies in the U.S. and Europe, including Pfizer, Novartis, Myriad Genetics and CareDx.

His leadership capabilities include delivery of strong commercial results, sourcing, structuring and executing dozens of partnering, M&A and other strategic transactions across the product life cycle, raising debt and equity capital in the private and public markets totaling over $500 million, and working with founders, management teams, and boards to address complex business issues to support their companies’ rapid growth.
Matt has been an entrepreneur at heart since his youth, when he started a travel services business from the basement of his family’s home. Since then, he has led the growth of five companies as an operating executive. Now from his position at Wilson Sonsini, Matthew helps entrepreneurs and enterprises start, grow and scale.

Matthew holds a B.A. degree in Government, cum laude and Phi Beta Kappa, from Cornell University and a J.D. degree from the Villanova University School of Law.